Financial News
Latest News about MRNA
Recent news which mentions MRNA
Moderna’s stock jumps 5% premarket after narrower-than-expected loss and revenue beat
August 03, 2023
From MarketWatch
US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month
August 03, 2023
From Benzinga
Apple and Amazon results may hold the key to any market rebound. Here’s the technical set-up.
August 03, 2023
From MarketWatch
3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now
August 02, 2023
From InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
August 01, 2023
From Benzinga
3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now
August 01, 2023
From InvestorPlace
Why Novavax Stock Zoomed 13% Higher on Monday
July 31, 2023
From Motley Fool
7 Stocks to Buy Before They Surpass 2021 Highs
July 31, 2023
From InvestorPlace
Merck Q2 Earnings Preview: Analyst Expectations, Jim Cramer's View, And The Spotlight On Keytruda
July 31, 2023
From Benzinga
From Benzinga
From InvestorPlace
As COVID-19 Cases Spike This Summer, Healthcare Experts See It As Recurring Theme And Recommend These Measures
July 29, 2023
From Benzinga
Worried about Lyme disease? CDC warns that 450,000 people may have been infected by a tick-related meat allergy.
July 28, 2023
Tickers
MRNA
Tags
MRNA
From MarketWatch
From Motley Fool
Individualized Cancer Treatment: Merck/Moderna's Personalized Skin Cancer Therapy Enters Late-Stage Of Development
July 26, 2023
From Benzinga
Moderna On Cathie Wood's Radar Ahead Of Q2 Results: Ark Boosts Stake In COVID-19 Vaccine Maker By $12M This Week
July 26, 2023
From Benzinga
Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna
July 24, 2023
From Benzinga
From InvestorPlace
Fentanyl Crisis In US: Biden Administration Contemplates Easing Sanctions on China's Forensic Institute
July 24, 2023
From Benzinga
From Benzinga
Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition
July 24, 2023
From Benzinga
Moderna Is Fairly Valued, Balancing Declining COVID-19 Base Business with Promising Future Pipeline: Analyst
July 24, 2023
From Benzinga
From Benzinga
Obey the Sell Signals: 3 Blue-Chip Stocks to Let Go
July 20, 2023
From InvestorPlace
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
